Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Strek, ME"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Autorzy:
Rahaghi FF; Respiratory Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA. .
Hsu VM; Rutgers-RWJ Medical School, New Brunswick, NJ, USA.
Kaner RJ; Weill Cornell Medicine, New York, NY, USA.
Mayes MD; University of Texas, Houston, TX, USA.
Rosas IO; Brigham and Women's Hospital, Boston, MA, USA.
Saggar R; University of California Los Angeles, Los Angeles, CA, USA.
Steen VD; Georgetown University, Washington, D.C, USA.
Strek ME; University of Chicago, Chicago, IL, USA.
Bernstein EJ; Columbia University Irving Medical Center, New York, NY, USA.
Bhatt N; Ohio State University, Columbus, OH, USA.
Castelino FV; Harvard Medical School, Boston, MA, USA.
Chung L; Stanford University School of Medicine and Palo Alto VA Health Care System, Stanford, CA, USA.
Domsic RT; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Flaherty KR; University of Michigan Scleroderma Clinic, Ann Arbor, MI, 48105, USA.
Gupta N; University of Cincinnati, Cincinnati, OH, USA.
Kahaleh B; University of Toledo Medical Center, Toledo, OH, USA.
Martinez FJ; Weill Cornell Medicine, New York, NY, USA.
Morrow LE; Creighton University, Omaha, NE, USA.
Moua T; Mayo Clinic, Rochester, MN, USA.
Patel N; Columbia University Irving Medical Center, New York, NY, USA.; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA.
Shlobin OA; Inova Fairfax Hospital, Falls Church, VA, USA.
Southern BD; Cleveland Clinic, Cleveland, OH, USA.
Volkmann ER; University of California Los Angeles, Los Angeles, CA, USA.
Khanna D; University of Michigan Scleroderma Clinic, Ann Arbor, MI, 48105, USA. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Jan 09; Vol. 24 (1), pp. 6. Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/drug therapy
Lung Diseases, Interstitial*/etiology
Scleroderma, Systemic*/complications
Scleroderma, Systemic*/diagnosis
Scleroderma, Systemic*/therapy
Humans ; Consensus ; Immunosuppressive Agents/therapeutic use ; Lung ; Mycophenolic Acid/therapeutic use
Czasopismo naukowe
Tytuł:
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
Autorzy:
Tyker A; Department of Internal Medicine, University of Chicago, Chicago, IL, 60637, USA. .
Ventura IB; Rheumatology, University of Chicago, Chicago, IL, USA.
Lee CT; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Strykowski R; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Garcia N; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Guzy R; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Jablonski R; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Vij R; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Strek ME; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Chung JH; Radiology, University of Chicago, Chicago, IL, USA.
Adegunsoye A; Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Nov 24; Vol. 11 (1), pp. 22821. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Arthritis, Rheumatoid/*blood
Lung Diseases, Interstitial/*etiology
Lymphadenopathy/*etiology
Mediastinal Diseases/*etiology
Rheumatoid Factor/*blood
Adult ; Aged ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/mortality ; Biomarkers/blood ; Disease Progression ; Female ; Humans ; Lung Diseases, Interstitial/blood ; Lung Diseases, Interstitial/diagnosis ; Lung Diseases, Interstitial/mortality ; Lymphadenopathy/blood ; Lymphadenopathy/diagnosis ; Lymphadenopathy/mortality ; Male ; Mediastinal Diseases/blood ; Mediastinal Diseases/diagnosis ; Mediastinal Diseases/mortality ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł:
Hospitalizations in patients with idiopathic pulmonary fibrosis.
Autorzy:
Kim HJ; University of Minnesota, Minneapolis, MN, USA. .
Snyder LD; Duke Clinical Research Institute, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA.
Adegunsoye A; Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL, USA.
Neely ML; Duke Clinical Research Institute, Durham, NC, USA.; Duke University Medical Center, Durham, NC, USA.
Bender S; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
White ES; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
Conoscenti CS; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
Strek ME; Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL, USA.
Pokaż więcej
Corporate Authors:
IPF-PRO Registry Investigators
Źródło:
Respiratory research [Respir Res] 2021 Sep 30; Vol. 22 (1), pp. 257. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Hospitalization*
Idiopathic Pulmonary Fibrosis/*therapy
Respiration, Artificial/*adverse effects
Aged ; Female ; Hospital Mortality ; Humans ; Idiopathic Pulmonary Fibrosis/diagnosis ; Idiopathic Pulmonary Fibrosis/mortality ; Male ; Patient Discharge ; Patient Readmission ; Prognosis ; Registries ; Respiration, Artificial/mortality ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; United States
Czasopismo naukowe
Tytuł:
Automated CT Analysis of Major Forms of Interstitial Lung Disease.
Autorzy:
Crews MS; Department of Radiology, The University of Chicago Medicine, Chicago, IL 60637, USA.
Bartholmai BJ; Department of Radiology, Mayo Clinic, Rochester, MN 55902, USA.
Adegunsoye A; Department of Medicine, The University of Chicago Medicine, Chicago, IL 60637, USA.
Oldham JM; Department of Medicine, The University of California Davis, Sacramento, CA 95616, USA.
Montner SM; Department of Radiology, The University of Chicago Medicine, Chicago, IL 60637, USA.
Karwoski RA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55902, USA.
Husain AN; Department of Pathology, The University of Chicago Medicine, Chicago, IL 60637, USA.
Vij R; Department of Medicine, The University of Chicago Medicine, Chicago, IL 60637, USA.
Noth I; Department of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
Strek ME; Department of Medicine, The University of Chicago Medicine, Chicago, IL 60637, USA.
Chung JH; Department of Radiology, The University of Chicago Medicine, Chicago, IL 60637, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Nov 23; Vol. 9 (11). Date of Electronic Publication: 2020 Nov 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat.
Autorzy:
Maher TM; National Institute for Health Research Respiratory Clinical Research Facility, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK. .; Fibrosis Research Group, National Heart and Lung Institute, Imperial College, Cale Street, London, SW3 6LY, UK. .
Strek ME; Section of Pulmonary & Critical Care Medicine, The University of Chicago, Chicago, IL, USA.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2019 Sep 06; Vol. 20 (1), pp. 205. Date of Electronic Publication: 2019 Sep 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Time-to-Treatment*/standards
Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage
Idiopathic Pulmonary Fibrosis/*diagnosis
Idiopathic Pulmonary Fibrosis/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Clinical Trials as Topic/methods ; Humans ; Idiopathic Pulmonary Fibrosis/metabolism ; Indoles/administration & dosage ; Pyridones/administration & dosage
Czasopismo naukowe
Tytuł:
Interstitial Pneumonia With Autoimmune Features: Value of Histopathology.
Autorzy:
Adegunsoye A
Oldham JM
Valenzi E
Lee C
Witt LJ
Chen L
Montner S
Chung JH
Noth I
Vij R
Strek ME
Husain AN; From the Section of Pulmonary and Critical Care Medicine, Department of Medicine (Drs Adegunsoye, Witt, Noth, Vij, and Strek and Ms Chen) and the Departments of Medicine (Drs Valenzi and Lee), Radiology (Drs Montner and Chung), and Pathology (Dr Husain), University of Chicago, Chicago, Illinois; and the Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, Davis (Dr Oldham). Drs Adegunsoye and Oldham contributed equally to this article.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2017 Jul; Vol. 141 (7), pp. 960-969. Date of Electronic Publication: 2017 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Autoimmunity*
Idiopathic Interstitial Pneumonias/*diagnosis
Pathology, Clinical/*methods
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Churg-Strauss syndrome.
Autorzy:
Noth I; Section of Pulmonary and Critical Care Medicine, Department of Medicine, and Committees on Clinical Pharmacology and Pharmacogenetics and Molecular Medicine, University of Chicago, Chicago, IL, USA.
Strek ME
Leff AR
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2003 Feb 15; Vol. 361 (9357), pp. 587-94.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Churg-Strauss Syndrome*/diagnosis
Churg-Strauss Syndrome*/drug therapy
Churg-Strauss Syndrome*/etiology
Churg-Strauss Syndrome*/physiopathology
Adrenal Cortex Hormones/*therapeutic use
Diagnosis, Differential ; Humans ; Prognosis
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies